18
Participants
Start Date
June 30, 2025
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Stem cells
The suspension of stem cells will be put in a medical nebulizer machine, commonly used to deliver medicines into the lungs through inhalation. This means that the participants will breathe in the mist containing the SMS cells, produced by the nebulizer machine. This is a Phase I First-in-Human study, which indicates that this treatment is being studied for the first time in humans.
RECRUITING
Veritas Research, Bayswater
Lead Sponsor
SMSbiotech
INDUSTRY